News
Also, Remidio receives a CE mark for its AI tool for detecting referable diabetic retinopathy.
Also, EpiSoft announces the integration of its cancer management platform with My Health Record.
In a proposed order, the online therapy company would also pay $7.8 million for allegedly sharing consumer data with third parties like Facebook and Snapchat for advertising purposes.
Drug-discovery platform TandemAI, sleep-care platform BetterNight, health-monitoring system Xandar Kardian and AR/VR platform Healium also announced funding rounds.
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
The digital health company reported $184.1 million in revenue for Q4, a 14% decline from the same period in 2021.
The wearable uses its motion sensors to determine if the user has taken a hard fall and can contact emergency services if they don't respond.
The mental health platform let go of 15% of its workforce.
The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.
DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.